Veru VERU
NASDAQ VERU
$2.56 +0.03 (+1.39%)
At close: Sep 29, 2026 · 4:00 PM EDT

Veru (VERU) Restructuring Costs (2016 - 2017)

Updated

Veru (VERU) reported Restructuring Costs of -$73,099 for fiscal Q4 2017 (quarter ended Sep 30, 2017).

Analysis

Veru (VERU) Restructuring Costs (2016 - 2017) Analysis & Trends

For FY2017 (ended Sep 30, 2017), Veru posted Restructuring Costs of $935,781, down 36.9% from FY2016.

  • By fiscal year, Restructuring Costs came in at $1.48 million in FY2016.
  • Per Business Quant data, the three fiscal quarters before Q4 2017 came in at $74,495 (Q3 2017), $108,015 (Q2 2017) and $826,370 (Q1 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Veru 58.32 Mn -51.96 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -73,099.00
Jun 30, 2017 74,495.00
Mar 31, 2017 108,015.00
Dec 31, 2016 826,370.00
API Access

Veru Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=VERU&period=max&api_key=YOUR_API_KEY